Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hackel

Showing results (361-370 of 482) with videos related to

Pageof 49
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2013
18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6Benjamin J Hackel, Richard H Kimura, Zheng Miao, et al.
ACS Synthetic Biology|August 29, 2023
Predicting and Interpreting Protein Developability Via Transfer of Convolutional Sequence RepresentationAlexander W Golinski, Zachary D Schmitz, Gregory H Nielsen, et al.
Molecular Pharmaceutics|October 5, 2016
<sup>64</sup>Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor ReceptorMax A Kruziki, Brett A Case, Jie Y Chan, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial PathogensD J Biedenbach, S K Bouchillon, M Hackel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2021
High-throughput developability assays enable library-scale identification of producible protein scaffold variantsAlexander W Golinski, Katelynn M Mischler, Sidharth Laxminarayan, et al.
Jac-Antimicrobial Resistance|July 5, 2021
<i>Escherichia coli</i> strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance studyTakafumi Sato, Akinobu Ito, Yoshino Ishioka, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
<i>In Vitro</i> Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)Sibylle H Lob, Meredith A Hackel, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Emerging Infectious Diseases|October 24, 2014
Global incidence of carbapenemase-producing Escherichia coli ST131Gisele Peirano, Patricia A Bradford, Krystyna M Kazmierczak, et al.
American Journal of Physiology. Cell Physiology|October 22, 2024
Healthy plasma lipidomic signatures depend on sex, age, body mass index, and contraceptives but not perceived stressLisa Hahnefeld, Juliane Hackel, Sandra Trautmann, et al.
Pageof 49

Showing results (361-370 of 482) with videos related to

Sort By:
Pageof 49
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 15, 2013
18F-fluorobenzoate-labeled cystine knot peptides for PET imaging of integrin αvβ6Benjamin J Hackel, Richard H Kimura, Zheng Miao, et al.
ACS Synthetic Biology|August 29, 2023
Predicting and Interpreting Protein Developability Via Transfer of Convolutional Sequence RepresentationAlexander W Golinski, Zachary D Schmitz, Gregory H Nielsen, et al.
Molecular Pharmaceutics|October 5, 2016
<sup>64</sup>Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor ReceptorMax A Kruziki, Brett A Case, Jie Y Chan, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2016
In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial PathogensD J Biedenbach, S K Bouchillon, M Hackel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2021
High-throughput developability assays enable library-scale identification of producible protein scaffold variantsAlexander W Golinski, Katelynn M Mischler, Sidharth Laxminarayan, et al.
Jac-Antimicrobial Resistance|July 5, 2021
<i>Escherichia coli</i> strains possessing a four amino acid YRIN insertion in PBP3 identified as part of the SIDERO-WT-2014 surveillance studyTakafumi Sato, Akinobu Ito, Yoshino Ishioka, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2017
<i>In Vitro</i> Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)Sibylle H Lob, Meredith A Hackel, Krystyna M Kazmierczak, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
<i>In Vitro</i> Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, et al.
Emerging Infectious Diseases|October 24, 2014
Global incidence of carbapenemase-producing Escherichia coli ST131Gisele Peirano, Patricia A Bradford, Krystyna M Kazmierczak, et al.
American Journal of Physiology. Cell Physiology|October 22, 2024
Healthy plasma lipidomic signatures depend on sex, age, body mass index, and contraceptives but not perceived stressLisa Hahnefeld, Juliane Hackel, Sandra Trautmann, et al.
Pageof 49